Cetin, B. Et Al. 2013. Is the Pretreatment Neutrophil to Lymphocyte Ratio an Important Prognostic Parameter in Patients with Metastatic Renal Cell Carcinoma?. CLINICAL GENITOURINARY CANCER , vol.11, no.2 , 141-148.

Cetin, B., Berk, V., Kaplan, M. A., Afsar, B., Tufan, G., Ozkan, M., ... Isikdogan, A.(2013). Is the Pretreatment Neutrophil to Lymphocyte Ratio an Important Prognostic Parameter in Patients with Metastatic Renal Cell Carcinoma?. CLINICAL GENITOURINARY CANCER , vol.11, no.2, 141-148.

Cetin, Bulent Et Al. "Is the Pretreatment Neutrophil to Lymphocyte Ratio an Important Prognostic Parameter in Patients with Metastatic Renal Cell Carcinoma?," CLINICAL GENITOURINARY CANCER , vol.11, no.2, 141-148, 2013

Cetin, Bulent Et Al. "Is the Pretreatment Neutrophil to Lymphocyte Ratio an Important Prognostic Parameter in Patients with Metastatic Renal Cell Carcinoma?." CLINICAL GENITOURINARY CANCER , vol.11, no.2, pp.141-148, 2013

Cetin, B. Et Al. (2013) . "Is the Pretreatment Neutrophil to Lymphocyte Ratio an Important Prognostic Parameter in Patients with Metastatic Renal Cell Carcinoma?." CLINICAL GENITOURINARY CANCER , vol.11, no.2, pp.141-148.

@article{article, author={Bulent Cetin Et Al. }, title={Is the Pretreatment Neutrophil to Lymphocyte Ratio an Important Prognostic Parameter in Patients with Metastatic Renal Cell Carcinoma?}, journal={CLINICAL GENITOURINARY CANCER}, year=2013, pages={141-148} }